Therapeutic protein production at WACKER’s Halle site. In 2013, Wacker Biotech GmbH, a wholly-owned Wacker Chemie AG subsidiary, acquired the production plants. The acquisition was an important step for WACKER, enabling it to support its customers in the pharmaceutical sector not only during clinical trials, but during the market supply phase, too